Celebrex (celecoxib) most commonly causes digestive issues like indigestion, diarrhea, and stomach pain. In clinical trials, roughly 9% of people taking Celebrex reported indigestion, compared to about 6% on a placebo. More serious but less common risks include cardiovascular events like heart attack and stroke, which carry an FDA black box warning. Here’s what to expect across the full range of side effects.
How Celebrex Differs From Other Pain Relievers
Celebrex belongs to a class of anti-inflammatory drugs that selectively blocks only one of the two enzymes responsible for producing prostaglandins, the chemical messengers that drive pain and inflammation. Traditional NSAIDs like ibuprofen and naproxen block both enzymes. The first enzyme (COX-1) plays a protective role in the stomach lining and helps platelets function normally. By sparing that enzyme, Celebrex reduces inflammation while causing less direct damage to the gut. This is the core trade-off that shapes its side effect profile: fewer stomach problems than traditional NSAIDs, but a cardiovascular risk that applies to all drugs in this category.
Common Digestive Side Effects
The most frequently reported side effects in premarket trials involving over 4,000 patients were gastrointestinal. Indigestion occurred in 8.8% of Celebrex users versus 6.2% on placebo. Diarrhea affected 5.6% compared to 3.8% on placebo, and abdominal pain showed up in 4.1% versus 2.8%. Gas and heartburn are also common but tend to be mild enough that most people don’t stop taking the medication. In the trials, fewer than 1% of participants discontinued Celebrex because of indigestion or abdominal pain.
Despite these digestive complaints, Celebrex causes significantly less actual damage to the stomach lining than traditional NSAIDs. In a head-to-head study comparing Celebrex to over-the-counter doses of ibuprofen over 10 days, only 2.6% of Celebrex users developed stomach ulcers on endoscopy, compared to 17.9% of ibuprofen users. That’s a meaningful difference if you need regular anti-inflammatory treatment and are concerned about ulcers or bleeding.
Cardiovascular Risks
Celebrex carries the FDA’s most serious label warning, a black box warning, for cardiovascular events. All NSAIDs, not just Celebrex, increase the risk of heart attack and stroke, and these events can be fatal. The risk can appear as early as the first weeks of treatment and tends to increase with higher doses and longer use. People with existing heart disease or risk factors face a higher absolute risk, though the relative increase applies to everyone.
Celebrex is specifically contraindicated right after coronary artery bypass graft surgery, where the cardiovascular risk is especially pronounced. For everyone else, the general guidance is to use the lowest effective dose for the shortest time needed. For osteoarthritis, that’s typically 200 mg per day. For rheumatoid arthritis, the range is 200 to 400 mg daily, split into two doses.
Effects on Kidney Function
All anti-inflammatory drugs can affect your kidneys because prostaglandins help regulate blood flow to the kidneys, control how the kidneys handle salt and water, and maintain overall kidney function during periods of stress. When those prostaglandins are suppressed, the kidneys become more vulnerable.
That said, Celebrex appears to be gentler on the kidneys than traditional NSAIDs. In a large study of adults with arthritis, even supratherapeutic doses of celecoxib (double the usual maximum) were associated with fewer kidney function abnormalities than standard doses of ibuprofen or diclofenac. Among patients who already had mildly reduced kidney function at the start, Celebrex was associated with a slower rate of decline compared to both of those alternatives. This doesn’t mean Celebrex is safe for people with serious kidney disease, but it does suggest a somewhat more favorable profile for those with mild impairment.
Rare but Serious Reactions
Severe side effects are uncommon but worth knowing about. These include serious stomach pain that could indicate a deep ulcer or perforation, liver problems (watch for yellowing skin, dark urine, or unusual fatigue), and severe skin reactions. Allergic reactions, including swelling of the face or throat and difficulty breathing, require immediate medical attention.
One common concern is whether people with a “sulfa allergy” need to avoid Celebrex, since celecoxib contains a sulfonamide group in its chemical structure. The answer, based on current evidence, is no. The allergic reactions people experience with sulfa antibiotics are driven by a specific chemical component (an arylamine group) that Celebrex and other nonantimicrobial sulfonamides simply don’t have. Because the structures responsible for triggering the immune response are absent, there is no cross-reactivity. This applies to both immediate allergic reactions and more severe delayed reactions like Stevens-Johnson syndrome. The FDA label still includes a general caution, but allergy specialists and recent clinical reviews have concluded that withholding Celebrex from patients with sulfa antibiotic allergies is unnecessary.
How to Minimize Your Risk
The single most important principle with Celebrex is using the lowest dose that controls your symptoms, for the shortest period that makes sense for your condition. For osteoarthritis, 200 mg per day is the standard starting point. Some people do well with 100 mg twice daily rather than a single dose, which can help maintain more consistent levels throughout the day.
Your individual risk depends heavily on your baseline health. If you have a history of heart disease, high blood pressure, or kidney problems, those conditions shape how cautiously Celebrex should be used. Age matters too: older adults are more susceptible to both the cardiovascular and gastrointestinal risks. People taking blood thinners, corticosteroids, or other NSAIDs at the same time face compounded risks for bleeding and kidney problems.
For many people, Celebrex occupies a useful middle ground. It provides strong anti-inflammatory relief with a better stomach safety profile than ibuprofen or naproxen, while its cardiovascular risk, though real, is comparable to other NSAIDs when used at recommended doses. The key is matching the drug to your specific risk factors rather than treating it as universally safe or universally dangerous.